Dynamic Technology Lab Private LTD Zynerba Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.27 - $4.64 $62,198 - $88,257	-19,021 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.23 - $4.3 $61,437 - $81,790	19,021 New	19,021 $63,000
Q1 2020 May 13, 2020	SELL	$2.9 - $6.16 $124,067 - $263,537	-42,782 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.61 - $8.57 $240,007 - $366,641	42,782 New	42,782 $258,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.